Product

Antimicrobial Peptide PL-5

Aliases

AMP PL-5 and Placebo, Antimicrobial Peptide PL-5 Topical Spray and Placebo

1 clinical trial

1 indication

Indication

Diabetic Foot Ulcers

Clinical trial

A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Antimicrobial Peptide PL-5 Topical Spray in Patients With Mild Infections of Diabetic Foot Ulcers

Status: Not yet recruiting, Estimated PCD: 2024-12-30